• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Annals of Long Term Care

  • Follow us on

Search

  • Home
  • ARCHIVES
    • Issues
    • Supplements/Webcasts
  • About Us
    • Mission Statement
    • Editorial Description
    • Editorial Board
    • Publishing Staff
    • Our Partners
    • AGS Affiliations
    • Reprints/Permissions
  • SUBMIT
    • Author Guidelines
    • Copyright Transfer Form
    • Author Disclosure Form
    • Submit Now
  • CONTACT
  • ADVERTISING
    • Print Rate Card
    • Online Rate Card
    • Classified Rate Card
    • Sales Contacts
  • Supplements/Special Projects
  • Journal News
  • WEBCASTS
    • Facing Postherpetic Neuralgia in LTC
    • Treatment for Postherpetic Neuralgia Pain
    • Case Study—LTC Patient Suffering from PHN

With the Expert on: Valvular Aortic Stenosis

  • Fri, 9/5/08 - 4:54pm
  • 0 Comments
  • 2382 reads
Author(s): 

Wilbert S. Aronow, MD, AGSF

Q: Should aortic valve replacement be performed in an 80-year-old person with symptomatic severe aortic stenosis?

A: Case Presentation
An 80-year-old, previously functionally independent woman taking no medications has a 6-month history of substernal chest pressure precipitated by exertion and relieved by rest, an episode of syncope 2 months ago, and dyspnea at rest for the past 2 days. Physical examination in her physician’s office revealed a blood pressure of 110/80 mm Hg, a regular pulse at a rate of 96/minute, and a respiratory rate of 26/minute. Abnormal physical findings included a carotid pulse with a prolonged upstroke time, moist crepitant rales heard at both lung bases posteriorly, an absent A2, audible third and fourth heart sounds heard at the apex, and a grade 2/6 systolic ejection murmur heard in the second right intercostal space that radiated down the left sternal border to the apex and upwards to the right carotid artery. The systolic ejection murmur was prolonged in duration and peaked in the second half of systole.

An electrocardiogram showed a regular sinus rhythm and left ventricular hypertrophy. A chest x-ray showed rounding of the left ventricular border and apex, poststenotic dilatation of the ascending aorta, and pulmonary vascular congestion. A Doppler echocardiogram showed severe valvular aortic stenosis with an aortic valve area of 0.6 cm2. (A normal aortic valve opening is at least 2 cm. In mild aortic stenosis, the valve opens 1.50-2.0 square cm; in moderate aortic stenosis, the open valve area ranges from 0.8-1.49 square cm; and in severe aortic stenosis, the open aortic valve area is calculated to be less than 0.8 square cm.) A 2-dimensional echocardiogram showed a left ventricular ejection fraction of 45%.

Should This Patient Be Referred for Aortic Valve Replacement?
This elderly woman has the 3 classic manifestations seen with severe aortic stenosis: (1) angina pectoris, (2) syncope or near syncope, and (3) congestive heart failure, all of which are class I indications for aortic valve replacement (AVR), according to the American College of Cardiology (ACC)/American Heart Association (AHA) guidelines.1 Her physical findings indicate severe valvular aortic stenosis confirmed by Doppler echocardiography. If the cardiac output becomes sufficiently decreased, the systolic ejection murmur may become decreased in intensity or absent once congestive heart failure develops. Her left ventricular ejection fraction of < 50% is another ACC/AHA class I indication for AVR.

A study showed that at 13-month mean follow-up (range 2-24 months), 18 of 18 elderly patients (100%) with unoperated severe valvular aortic stenosis and a decreased left ventricular ejection fraction had died.2

AVR is the only definitive therapy in patients with symptomatic severe aortic stenosis. Medical therapy does not relieve the mechanical obstruction to left ventricular outflow and does not relieve symptoms or progression of the disorder.

A United Kingdom heart valve registry observed in 1100 patients aged ≥ 80 years (56% women) who underwent AVR that the 30-day mortality was 6.6%.3 The actuarial survival was 89% at 1 year, 79% at 3 years, 69% at 5 years, and 46% at 8 years.3 In 242 patients (mean age, 83 y) with aortic stenosis who had AVR, actuarial survival was 92% at 1 year and 66% at 5 years. Concomitant coronary artery bypass graft surgery did not affect late survival.4

Conclusion
In this previously functionally independent older woman with symptomatic severe aortic stenosis, AVR should be recommended to improve symptoms and prolong survival.

References
1. Bonow RO, Carabello BA, Chatterjee K, et al. ACC/AHA 2006 practice guidelines for the management of patients with valvular heart disease: Executive Summary.

image description image description
  • 1
  • 2
  • next ›
  • last »



Post new comment

  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
  • Use to create page breaks.

More information about formatting options

Image CAPTCHA
Enter the characters shown in the image.

LATEST NEWS

  • FDA Finally Approves Once-Weekly Type 2 Diabetes Treatment
    [Amylin] 1-31-12
  • FDA approves Voraxaze to treat patients with toxic methotrexate levels
    [FDA] 1-17-12
  • FDA approves first generic version of cholesterol-lowering drug Lipitor
    [FDA] 11-30-11
  • AHRQ Awards $34 Million To Expand Fight Against Healthcare-Associated Infections
    [AHRQ] 11-17-11
more »

Poll

Are nutritional supplements underutilized in long-term care?:

Classified/Recruitment Opportunities

  • Advertise Your Job Here
more »

ALTC Blogs

How to Create Collegiality in a Difference of Opinion: Part 2

Neil Baum MD
2/6/12 | 0 Comments | 13 reads

How to Create Collegiality in a Difference of Opinion: Part 1

Neil Baum MD
2/3/12 | 0 Comments | 41 reads

Dutasteride vs Low Grade Prostate Cancer

Alvin B Lin MD FAAFP
1/31/12 | 0 Comments | 64 reads
more »
banner banner banner banner banner
HMP Communications © 2012 HMP Communications
  • Home
  • About Us
  • Other Publications
  • Contact Us
  • Privacy Policy

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. © 2012 HMP Communications